Points to consider on integration of environmental sustainability strategies and metrics into pharmaceutical manufacturing.
The article focuses on the integration of environmental sustainability strategies and metrics into pharmaceutical manufacturing, providing a comprehensive framework intended for manufacturers, regulators, inspectors, and related stakeholders. It outlines risk-based, measurable, and auditable approac...
| Publicado en: | WHO Drug Information Vol. 40; no. 2; pp. 387 - 433 |
|---|---|
| Formato: | equations & formulas glossary tables/charts Journal Article |
| Publicado: |
World Health Organization
2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195521314&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 195521314 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10109609 6FV jtl: WHO Drug Information issn: 10109609 maglogo: N pubinfo: dt: 2026 vid: 40 iid: 2 pid: 437 pub: World Health Organization artinfo: ui: 195521314 195521314 195521314 195521314 ppf: 387 ppct: 46 formats: fmt: @attributes: type: P tig: atl: Points to consider on integration of environmental sustainability strategies and metrics into pharmaceutical manufacturing. aug: sug: subj: Environmental Sustainability Environmental Monitoring Quality Management, Organizational Quality Control (Technology) Manufacturing Industry Drugs Risk Assessment Nomenclature Life Cycle Excipients Drug Development Drug Packaging Medical Waste Disposal Sterilization and Disinfection Water Solvents Carbon Footprint Research, Medical Documentation Reports Materials Management Digital Technology Organizational Culture Staff Development Organizational Policies Accountability Conservation of Natural Resources Data Management Greenhouse Gases Life Cycle Evaluation Audit Government Regulations ab: The article focuses on the integration of environmental sustainability strategies and metrics into pharmaceutical manufacturing, providing a comprehensive framework intended for manufacturers, regulators, inspectors, and related stakeholders. It outlines risk-based, measurable, and auditable approaches to incorporate sustainability principles—such as green chemistry, energy and water efficiency, waste minimization, solvent management, and carbon footprint assessment—within good manufacturing practices (GMP) without compromising product quality, patient safety, or regulatory compliance. Key metrics discussed include Process Mass Intensity (PMI), Environmental Factor (E-factor), atom economy, carbon intensity, and Scope 1–3 greenhouse gas emissions, supported by life cycle assessment (LCA) methodologies to evaluate environmental impacts across product lifecycles. The document emphasizes management responsibilities, training, digital technology applications, and regulatory considerations to promote harmonized, practical, and continuous improvement approaches aligned with international standards and the United Nations Sustainable Development Goals. pubtype: Academic Journal doctype: equations & formulas glossary tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|